Amivantamab 1 Antibodies, Bispecific 1 Drug Resistance, Neoplasm 1 EGFR amplification 1 EGFR protein, human 1 EGFR triple mutation EGFR/MET dual inhibition 1 Epidermal Growth Factor 1 ErbB Receptors 1 Humans 1 L858R/T790M/G796S 1 Lung Neoplasms 1 Mutation 1 Osimertinib esistance 1 Protein Kinase Inhibitors 1 Trogocytosis 1 amivantamab 1 bi-specific antibody 1 bispecific antibody 1 drug resistance 1 epidermal growth factor 1 epidermal growth factor receptor 1 genetics 1 human 1 lung tumor 1 mutation 1 protein kinase inhibitor 1